Phreesia, Inc. (NYSE:PHR – Get Rating) SVP Michael J. Davidoff sold 1,296 shares of the company’s stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $27.60, for a total value of $35,769.60. Following the completion of the sale, the senior vice president now owns 108,312 shares in the company, valued at approximately $2,989,411.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Phreesia Stock Down 1.1 %
PHR stock opened at $27.40 on Tuesday. The business’s 50-day moving average price is $24.69 and its 200-day moving average price is $24.00. The stock has a market cap of $1.44 billion, a P/E ratio of -7.85 and a beta of 0.75. Phreesia, Inc. has a twelve month low of $13.19 and a twelve month high of $76.10. The company has a quick ratio of 4.40, a current ratio of 4.40 and a debt-to-equity ratio of 0.01.
Hedge Funds Weigh In On Phreesia
Hedge funds have recently modified their holdings of the company. Captrust Financial Advisors boosted its holdings in Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after buying an additional 866 shares during the period. Assetmark Inc. boosted its stake in shares of Phreesia by 42.2% in the second quarter. Assetmark Inc. now owns 1,685 shares of the company’s stock worth $42,000 after acquiring an additional 500 shares during the period. Advisor Group Holdings Inc. raised its stake in Phreesia by 63.4% during the 4th quarter. Advisor Group Holdings Inc. now owns 1,319 shares of the company’s stock valued at $55,000 after purchasing an additional 512 shares during the period. Hardy Reed LLC purchased a new position in Phreesia in the 1st quarter worth approximately $65,000. Finally, BloombergSen Inc. boosted its stake in Phreesia by 57.1% in the 2nd quarter. BloombergSen Inc. now owns 5,500 shares of the company’s stock worth $138,000 after purchasing an additional 2,000 shares during the period. 89.39% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.
- Get a free copy of the StockNews.com research report on Phreesia (PHR)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.